BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

triple uptake inhibitors 2008 Pages on BioPortfolio:

BioPortfolio - triple uptake inhibitors 2008
Recent Search Terms used to find this page: dov pharmaceuticals somerset | clinical trials biovail | triple uptake inhibitors 2008 | vat . ...
http://www.bioportfolio.com/search/triple_uptake_inhibitors_...

BioPortfolio - DOV Pharmaceutical - Profile
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... Montana's News Station: Oct 28 2008 9:53PM Matching: dov pharmaceutical ...
http://www.bioportfolio.com/biocorporate/3500-DOV%2BPharmace...

BioPortfolio - DOV Pharmaceutical - Profile
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... Neurocrine Biosciences Reports Third Quarter 2008 Results ...
http://www.bioportfolio.com/biocorporate/3500-DOV+Pharmaceut...

BioPortfolio - tolerability of amine uptake inhibitors in urologic ...
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... 2008]; Tolerability of amine uptake inhibitors in urologic diseases. ...
http://www.bioportfolio.com/search/tolerability_of_amine_upt...

BioPortfolio - DOV Pharmaceutical
2008 Mar;11(3):189-97. The triple uptake inhibitor (1R,5S)-(+)-1-(3,4- dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces
body ...
http://www.bioportfolio.com/biocorporate/3500-DOV_Pharmaceut...

BioPortfolio - Autism - InDepth
Stepping Stones Triple P: An RCT of a Parenting Program with Parents of a Child ... re-uptake inhibitors. • 7407980- Imidazolinylmethyl aralkylsulfonamides ...
http://www.bioportfolio.com/indepth/Autism.pdf...

BioPortfolio - sepracor inhibitors
26 Sep 2008 ... BioPortfolio - Sepracor 27 Jun 2008 . ... Pipeline Drugs 7.1 Triple Uptake Inhibitors - the Next Step From SSNRIs 7.1.1 (R )-Sibutramine ...
http://www.bioportfolio.com/search/sepracor_inhibitors.html...

BioPortfolio - Lilly - Profile
Drug Discovery News: Nov 22 2008 10:15AM Matching: lilly ... 7432280- 3- aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake ...
http://www.bioportfolio.com/biocorporate/6488-Lilly.pdf...

BioPortfolio - Sankyo Co Limited
To obtain compounds that promote glucose uptake in muscle cells, the novel. ... is a novel ACAT inhibitor. The pharmacokinetics of... 13th November, 2008 ...
http://www.bioportfolio.com/biocorporate/9142-Sankyo_Co_Limi...

BioPortfolio - biochemical pharmacology Roche Pharmaceuticals
BioPortfolio - triple uptake inhibitors 2008 20th September, 2008, Biochemical Pharmacology, Roche Pharmaceuticals. ... http: ...
http://www.bioportfolio.com/search/biochemical_pharmacology_...

Results from other life science and pharmaceutical sites:

Triple uptake inhibitors: therapeutic potential in...[Expert Opin ...
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... 2008]; Comparison of the effects of antidepressants and their metabolites on ...
http://www.ncbi.nlm.nih.gov/pubmed/17714023...

BioPortfolio - DOV Pharmaceutical - Profile
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... Montana's News Station: Oct 28 2008 9:53PM Matching: dov pharmaceutical ...
http://www.bioportfolio.com/biocorporate/3500-DOV%2BPharmace...

The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3 ...
2008 Mar;324(3):1111-26. Epub 2007 Dec 18. The triple uptake inhibitor (1R,5S)-( +)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV ...
http://www.ncbi.nlm.nih.gov/pubmed/18089843...

BioPortfolio - DOV Pharmaceutical - Profile
Triple uptake inhibitors: therapeutic potential in depression and beyond. ... Neurocrine Biosciences Reports Third Quarter 2008 Results ...
http://www.bioportfolio.com/biocorporate/3500-DOV+Pharmaceut...

The triple monoaminergic reuptake inhibitor DOV 21...[Eur ...
2008 Sep 11. [Epub ahead of print] Click here to read Links ... We tested the triple uptake inhibitor (TUI), DOV 216303 (5, 10 and 20 mg/kg) after 1, ...
http://www.ncbi.nlm.nih.gov/pubmed/18789657/...

Michele Phelps Phil 2008-02-14T15:11:01Z
Michele Phelps Phil 2008-02-14T15:11:01Z 2001-07-25T16:54:03Z .... 372475 ** triple (5HT/noradrenaline/dopamine) re-uptake inhibitor depression NCE II ...
http://www.gsk.com/investors/product_pipeline/v3.xml...

In-vitro and in-vivo characterization of JNJ-7925476, a novel ...
Epub 2008 Apr 10. In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor. Aluisio L, Lord B, Barbier AJ, Fraser IC, ...
http://www.ncbi.nlm.nih.gov/pubmed/18499098...

Pharmaceutical Collaborations 2008 – an SMi conference
BMS and Albany Molecular Research Inc (AMRI) for triple. reuptake inhibitors. ... AMRI's amine neurotransmitter uptake inhibitor program. ...
http://www.biomedcentral.com/content/pdf/cd-900110.pdf...

D-161, a novel pyran-based triple monoamine transporter blocker ...
Epub 2008 May 20. D-161, a novel pyran-based triple monoamine transporter blocker: ... Adrenergic Uptake Inhibitors; Antidepressive Agents; D-161 compound
...
http://www.ncbi.nlm.nih.gov/pubmed/18561912...

Product Development Pipeline February
triple (5HT/noradrenaline/dopamine) re-uptake. depression. II. inhibitor ... restless legs syndrome. lll. 2008. Lamictal XR. sodium channel inhibitor ...
http://www.gsk.com/investors/product_pipeline/docs/gsk-pipel...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.